University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides ...

Johns Hopkins University data reflects the public health reversal in defeating the vaccine-preventable disease since measles ...

The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.

Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

Vaccination programs have saved lives – and saved the Canadian economy and health care system significant resources as well ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine ...

As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Medical associations representing hundreds of thousands of doctors, medical professionals and scientists in the United States ...